EVALUATION OF EXTRACORPOREAL GAS EXCHANGE DEVICE HEMOLUNG FOR POTENTIAL APPLICATION IN PEDIATRIC PRACTICE

Aim. The main purpose of this work is to evaluate the Hemolung pumping ability and gas exchange effectiveness while using the catheters of smaller diameter and blood fl ow rates, applied in pediatrics.

Material and methods. The bench testing of the device with pediatric catheters has been performed. The bovine blood and carboxymethylcellulose water solution were used as a model. The device operation data, blood gas analysis and hydrodynamic pressure data were collected.

Results.The pump curve results show that at the maximum rotation rate the Hemolung device was able to achieve blood fl ow rates substantially greater than targeted 280 ml/min that is used in pediatrics. The calculated operating curve plotted against the observed pressure-fl ow relationships shows that the device could be able to operate against pressure heads of 80 and 100 mm Hg. In general, carbon dioxide elimination rate increased along with increase of the rotation rate, reaching maximum levels of 168 ± 0.3 ml CO2/min at 1750 RPM and a blood fl ow rate of 670 ± 42 ml/min. As a passive oxygenator, the small gas exchange fi ber surface area of the Hemolung resulted in oxygen saturations of 81% and 78% at 1.5 and 2.0 L/min, respectively.

Conclusion. The results of this study show the prospect of application of the Hemolung system in pediatrics.

1. Lick SD, Zwischenberger JB. Artifi cial lung: bench toward bedside. ASAIO J. 2004; 50: 2–5.

2. Federspiel WJ, Svitek RG. Lung, artifi cial: current research and future directions. Wnek GE, Bowlin GL, eds. Encyclopedia of Biomaterials and Biomedical Engineering. New York: Marcel Dekker, Inc, 2004: 922–931.

3. Conrad SA, Zwischenberger JB, Eggerstedt JM, Bidani A. In vivo gas transfer performance of the intravascular oxygenator in acute respiratory failure. Artif Organs. 1994; 18: 840–845.

4. Makarewicz AJ, Mockros LF, Anderson RW. A dynamic intravascular artifi cial lung. ASAIO J. 1994; 40: 747–750.

5. Snider MT, High KM, Richard RB et al. Small intrapulmonary artery lung prototypes: design, construction, and in vitro water testing. ASAIO J. 1994; 40: 533–539.

6. Hattler BG, Reeder GD, Sawzik PJ et al. Development of an intravenous membrane oxygenator: enhanced intravenous gas exchange through convective mixing of blood around hollow fi ber membranes. Artif Organs. 1994; 18: 806–812.

7. Eash HJ, Budilarto SG, Hattler BG, Federspiel WJ. Investigating the effects of random balloon pulsation on gas exchange in a respiratory assist catheter. ASAIO J. 2006; 52: 192–195.

8. Sato H, McGillicuddy JW, Griffi th GW et al. Effect of artifi cial lung compliance on in vivo pulmonary system hemodynamics.ASAIO J. 2006; 52: 248–256.

9. Cook KE, Perlman CE, Seipelt R, Backer CL, Mavroudis C, Mockros LF. Hemodynamic and gas transfer properties of a compliant thoracic artifi cial lung. ASAIO J. 2005; 51: 404–411.

10. Matheis G. New technologies for respiratory support. Perfusion. 18: 245–251.

11. Mueller XM, Jegger D, Augstburger M, Horisberger J, Godar G, von Segesser LK. A new concept of integrated cardiopulmonary bypass circuit. Eur J Cardiothorac Surg. 2002: 21: 840–846.

12. Tatsumi E, Takano H, Taenaka Y et al. Development of an ultracompact integrated heart-lung assist device. Artif Organs. 1999: 23: 518–523.

13. Wu ZJ, Holmes JA, Griffi th BP, Gartner MJ. Flow dynamics of an active mixing pump-oxygenator. ASAIO J. 2001; 47: 133.

14. Wu ZJ, Gartner M, Litwak KN, Griffi th BP. Progress toward an ambulatory pump-lung. J Thorac Cardiovasc Surg. 2005; 130: 973–978.

15. Available from: http.://www.alung.com/

16. Meurs K, Lally KP, Peek G, Zwischenberger JB ed. ECMO–Extracorporeal Cardiopulmonary Support in Critical Care, 3rd ed. Ann Arbor, MI: Extracorporeal Life Support Organization. 2005; 278.

17. Meurs K, Lally KP, Peek G, Zwischenberger JB ed. ECMO–Extracorporeal Cardiopulmonary Support in Critical Care, 3rd ed. Ann Arbor, MI: Extracorporeal Life Support Organization. 2005; 10.